BioSpace News Archive

Prices projected to increase over previous estimates, driven by newly released products such as cellular and gene therapies

CannaOne Technologies Inc. (CSE: CNNA; OTC: CNONF; and Frankfurt: 3CT) (“CannaOne” or the “Company”), a leading cannabis e-commerce technology company, is pleased to provide highlights of the updates and improvements made to its proprietary online marketplace software developed exclusively for the cannabis industry.

OPTIMUM Phase 3 study data presented for the first time during oral presentation at the 35th Congress of The European Committee for Treatment and Research in Multiple Sclerosis

In each position, Rhodes held many integral roles in client relations, operations and human resources.

The 4th Annual Nursing World Conference concluded August 21st at the Park Inn by Radisson Hotel & Conference Centre, providing qualitative, quantitative, and mixed-method research presented by Chief Nurses from around the globe.

The collaboration offers a cost-effective and efficient non-narcotic therapy solution for post-operative pain management.

CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD).

RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced key leadership members will be participating in the following upcoming industry events this fall:

As September shines a spotlight on childhood cancer awareness, the National Pediatric Cancer Foundation (NPCF) is bringing like-minded organizations together to find a faster cure with its new “Join Us” campaign.

NanoView Biosciences, Inc., and Quantum Design Korea, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView™ platform in South Korea.